Skip to main content

Table 3 Proportion of Participants Adhering to their Chosen CHD Risk Reduction Therapy at 3-month Follow-up

From: A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies

Chosen therapy (number in analysis)

Control % (n/N)

Intervention %(n/N)

Absolute difference (95% CI) (p-value)*

Odds ratio (95% CI)*

Adjusted absolute difference, p-value†

Adjusted odds ratio (95% CI) †

Any chosen therapy promoted by intervention (n = 149) ‡

34% (25/73)

59% (45/76)

25%

(8% to 42%)

(p < 0.01)

2.8

(1.3 to 5.9)

25%, p < 0.01

3.4

(1.4 to 6.9)

Any chosen therapy, including other§ (n = 154)

68% (52/77)

83% (64/77)

16%

(4% to 28%)

(p = 0.02)

2.4

(1.2 to 4.9)

14%, p = 0.04

2.2

(1.0 to 4.8)

Take aspirin (n = 51)

58% (11/19)

94% (30/32)

36%

(17% to 55%)

(p < 0.01)

10.9 (2.0 to 59)

39%, p < 0.01

12.8

(2.0 to 84)

Take cholesterol medicine (n = 20)

83% (5/6)

86% (12/14)

3%

(-28% to 33%)

1.2

(0.1 to 12.3)

--

--

Take blood pressure medicine (n = 21)

92% (11/12)

100% (9/9)

8%

(-9% to 25%)

--||

--

--

Stop smoking (n = 13)

20% (1)

25% (2)

--

--

--

--

  1. Abbreviations: CHD = Coronary Heart Disease
  2. * Adjusted for clustering within physician
  3. † Adjusted for education level, and random effects of clustering within physician
  4. ‡ "Any chosen therapy promoted by intervention" includes hypertension med, cholesterol med, smoking cessation, aspirin
  5. § "Any chosen therapy, including other" includes hypertension med, cholesterol med, smoking cessation, aspirin, diet, and physical activity
  6. || Unable to calculate due to small cell size